Table 3 Reconstructive complication analysis among patients with and without NACT
Short-term complication (<  30 days) | All | NACT | Non-NACT | OR (95% CI) of NACT | p value |
|---|---|---|---|---|---|
 Any complication | 50 (19.2) | 10 (21.7) | 40 (18.7) | 1.56 (0.63–3.86) | 0.334 |
 Re-exploration | 3 (1.2) | 1 (2.2) | 2 (0.9) | 0.79 (0.00–145.23) | 0.930 |
 Infection | 2 (0.8) | 0 (0.0) | 2 (0.9) | N/A | N/A |
 Mastectomy skin flap necrosis | 15 (5.8) | 3 (6.5) | 12 (5.6) | 1.28 (0.29–5.60) | 0.743 |
 Nipple necrosis | 6 (2.3) | 2 (4.3) | 4 (1.9) | 1.57 (0.19–13.09) | 0.675 |
 Seroma | 7 (2.7) | 1 (2.2) | 6 (2.8) | 1.58 (0.15–16.81) | 0.707 |
 Hematoma | 4 (1.5) | 2 (4.3) | 2 (0.9) | N/A | N/A |
 Expander/Implant exposure | 1 (0.4) | 0 (0.0) | 1 (0.5) | N/A | N/A |
 Poor wound healing | 33 (12.7) | 5 (10.9) | 28 (13.1) | 1.00 (0.32–3.10) | 0.996 |
 Implant failure | 1 (0.4) | 0 (0.0) | 1 (0.5) | N/A | N/A |
Long-term complication (>  30 days) | |||||
 Any complication | 45 (17.3) | 8 (17.4) | 37 (17.3) | 0.71 (0.25–1.96) | 0.502 |
 Infection | 11 (4.2) | 4 (8.7) | 7 (3.3) | 3.26 (0.69–15.26) | 0.134 |
 Expander/Implant exposure | 4 (1.5) | 0 (0.0) | 4 (1.9) | N/A | N/A |
 Implant rupture | 9 (3.5) | 0 (0.0) | 9 (4.2) | N/A | N/A |
 Capsular contracture | 24 (9.2) | 3 (6.5) | 21 (9.8) | 0.37 (0.08–1.67) | 0.195 |
 Contracture release | 13 (5.0) | 1 (2.2) | 12 (5.6) | 0.15 (0.01–1.93) | 0.144 |
 Implant failure | 15 (5.8) | 0 (0.0) | 15 (7.0) | N/A | N/A |